Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Annovis Bio Inc (ANVS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Annovis Bio's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.20 -0.25    -4.59%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
5.28
+0.08
+1.54%
17:36:36 - Real-time Data
  • Volume: 603,186
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 4.86 - 5.73
Type:  Equity
Market:  United States
Annovis Bio 5.20 -0.25 -4.59%

Annovis Bio Inc Company Profile

 
Get an in-depth profile of Annovis Bio Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

11

Equity Type

ORD

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company’s lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer’s disease (AD), Parkinson’s disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.

Contact Information

Address 101 Lindenwood Drive Suite 225
Malvern, 19355
United States
Phone (484) 875-3192
Fax -

Top Executives

Name Age Since Title
Michael M. B. Hoffman 74 2014 Independent Chairman of the Board
Claudine E. Bruck 68 2015 Independent Director
Gregory A. Petsko - 2017 Member of Scientific Advisory Board
Jeffrey L. Cummings 74 - Chief Medical Advisor & Member of Scientific Advisory Board
Mark K. White 67 2016 Independent Director
Sidney Strickland - 2017 Chairman of Scientific Advisory Board
Reid S. McCarthy 69 2021 Independent Director
Maria L. Maccecchini 73 2008 Founder, CEO, President & Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ANVS Comments

Write your thoughts about Annovis Bio Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
The Right Path
The Right Path May 21, 2021 15:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it go up Monday?
Rick Bron
Rick Bron May 21, 2021 15:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maybe, potential for another short squeeze as im sure its heavily shorted now with low float
The Right Path
The Right Path May 21, 2021 15:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it go up Monday?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email